Capital expenditure increased 157.1%
Capital expenditure changed +157.1% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +157.1% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Revenue changed +37.3% from the comparable as-filed period.
Cash & equivalents changed +137.9% from the comparable as-filed period.
Capex / revenue changed +503 basis points from the comparable as-filed period.
Free-cash-flow proxy changed -193.5% from the comparable as-filed period. The change ranks at the 67th percentile of 6 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Operating cash flow changed -171.0% from the comparable as-filed period. The change ranks at the 33th percentile of 6 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
SBC / revenue changed -115 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed +4.2% from the comparable as-filed period.
Stock-based compensation changed +0.8% from the comparable as-filed period. The change ranks at the 0th percentile of 5 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.